3Q EARNINGS: Celgene reports higher operating profit on cancer drug sales
This article was originally published in Scrip
Executive Summary
Celgene reported higher third-quarter operating profit on strong sales of its cancer drugs. The big US biotech company raised its own forecast for full-year profit and revenue.